Olverembatinib: A New Treatment for Adult Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
Cancers · 18.06.2026 · 18 (12) · 1990
DOI: 10.3390/cancers18121990 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 18.06.2026. Verfasst von Xavier Thomas. Beteiligte Einrichtung: Hospices Civils de Lyon, Department of Clinical Hematology, Centre Hospitalier Universitaire, F-69003 Lyon, France. Die Arbeit nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background/Objectives: The prognosis of patients with Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL) has improved with the addition of tyrosine kinase inhibitors (TKIs) to conventional chemotherapy. However, there are limited therapeutic options for patients resistant or intolerant to current TKIs.
Methods
A comprehensive search was made on PubMed.ncbi.nlm.nih.gov for published studies and ClinicalTrials.gov for registered trials, regarding the first results of and promising strategies with olverembatinib, a novel third-generation TKI, for the treatment of Ph+ ALL.
Results
First trials involving olverembatinib showed significant anti-leukemic clinical activity both in newly diagnosed and relapsed/refractory patients with Ph+ ALL, especially those harboring the T315I mutation. Furthermore, olverembatinib demonstrated a favorable tolerability compared with the other TKIs.
Conclusions
This augurs a new era in the standard of care for many patients with unmet clinical needs. However, further studies are warranted to assess olverembatinib’s real value and its cost-effectiveness.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Hospices Civils de Lyon, Department of Clinical Hematology, Centre Hospitalier Universitaire, F-69003 Lyon, France.
ORCID-Profile: Xavier Thomas
Zitieren
APA
Thomas, X. (2026). Olverembatinib: A New Treatment for Adult Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia. Cancers, 18(12), 1990. https://doi.org/10.3390/cancers18121990
Vancouver
Thomas X. Olverembatinib: A New Treatment for Adult Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia. Cancers. 2026;18(12):1990. doi:10.3390/cancers18121990
BibTeX
@article{Thomas2026,
author = {Thomas, Xavier},
title = {Olverembatinib: A New Treatment for Adult Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia},
journal = {Cancers},
year = {2026},
volume = {18},
number = {12},
pages = {1990},
doi = {10.3390/cancers18121990}
}
EUVIMED